RBC Capital Reiterates Outperform on Insulet, Maintains $280 Price Target

Insulet

Insulet

PODD

0.00

RBC Capital analyst Shagun Singh reiterates Insulet (NASDAQ: PODD) with a Outperform and maintains $280 price target.